1dMed, Shanghai, China,2Feinberg School of Medicine, Northwestern University,3Sanofi (retired), Bridgewater, NJ, USA
#CorrespondenceJun Shi
(jun.shi@dMedGlobal.com)
Running headClinical trial design for COVID-19 drug therapies
KeywordsSARS-COV-2, COVID-19, drug development, translational science, clinical
trial design, antiviral drugs
Scope: Review article